Eprobemide

Systematic (IUPAC) name
4-Chloro-N-[3-(4-morpholinyl)propyl]benzamide
Clinical data
Trade names	Befol (RU)
Legal status	℞ (Prescription only)
Routes of administration	Oral
Identifiers
CAS Number	87940-60-1
PubChem	CID: 65659
ChemSpider	59094
ChEMBL	CHEMBL2104298
Synonyms	Befol
Chemical data
Formula	C14H19ClN2O2
Molecular mass	282.77 g/mol
SMILES C1COCCN1CCCNC(=O)C2=CC=C(C=C2)Cl
InChI InChI=1S/C14H19ClN2O2/c15-13-4-2-12(3-5-13)14(18)16-6-1-7-17-8-10-19-11-9-17/h2-5H,1,6-11H2,(H,16,18) Key:YYFGRAGNYHYWEZ-UHFFFAOYSA-N

Eprobemide (INN) is a pharmaceutical drug that was used as an antidepressant in Russia (under the brand name Бефол/Befol). It is a non-competitive reversible inhibitor of monoamine oxidase A that exhibits selective action on serotonin deamination. Eprobemide differs from moclobemide only in linker that connects morpholine fragment with chlorobenzamide—moclobemide has two carbon atoms while eprobemide has three. Its registration was cancelled on December 30, 2003.